Molecular analysis of styrene oxide-induced hprt mutation in human T-lymphocytes

Mutagenesis

Volumn 11, Issue 6, 1996, Pages 581-591

  Bastlová, Tatiana ^a   Podlutsky, Andrej ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b INSTITUTE OF THEORETICAL AND EXPERIMENTAL BIOPHYSICS   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; MUTAGENIC AGENT; STYRENE; STYRENE OXIDE;

ARTICLE; CHEMICAL MUTAGENESIS; CONTROLLED STUDY; DELETION MUTANT; DNA ADDUCT; DNA SEQUENCE; FRAMESHIFT MUTATION; GENE AMPLIFICATION; GENE FREQUENCY; GENE LOCUS; GENE MUTATION; HUMAN; HUMAN CELL; LYMPHOCYTE CULTURE; MALE; MUTAGEN TESTING; MUTATION RATE; NORMAL HUMAN; NUCLEIC ACID BASE SUBSTITUTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

EID: 0029957945     PISSN: 02678357     EISSN: None     Source Type: Journal    
DOI: 10.1093/mutage/11.6.581     Document Type: Article

References (49)

1. Andersson, B., Fält, S. and Lambert, B. (1992) Strand specificity for mutations induced by (+)-anti BPDE in the hprt gene in human T-lymphocytes. Mutat. Res., 269, 129-140.
2. Arredondo-Vega, F.X., Santisteban, I., Kelly, S., Schlossman, C.M., Umetsu, D.T. and Hershfield, M.S. (1994) Correct splicing despite mutation of the invariant first nucleotide of a 5′ splice site: a possible basis for disparate clinical phenotypes in siblings with adenosine deaminase deficiency. Am. J. Hum. Genet., 54, 820-830.
3. Barzilay, G. and Hickson, I.D. (1995) Structure and function of apurinic/ apyrimidinic endonucleases. BioEssays, 17, 713-719.
4. Bastlová, T., Andersson, B., Lambert, B. and Kolman, A. (1993) Molecular analysis of ethylene oxide-induced mutations at the HPRT locus in human diploid fibroblasts. Mutat. Res., 287, 283-292.
5. Bastlová, T., Vodička, P., Peterková, K., Hemminki, K. and Lambert, B. (1995) Styrene oxide-induced HPRT mutations, DNA adducts and DNA strand breaks in cultured human lymphocytes. Carcinogenesis, 16, 2357-2362.
6. Belgrader, P. and Maquat, L.E. (1994) Nonsense but not missense mutations can decrease the abundance of nuclear mRNA for the mouse major urinary protein, while both types of mutations can facilitate exon skipping. Mol. Cell Biol., 14, 6326-6336.
7. Belvedere, G., Tursi, F. and Vainio, H. (1983) Non-microsomal activation of styrene to styrene oxide. In Rydström, I., Montelius, J. and Bengtsson, M. (eds), Extrahepatic Drug Metabolism and Chemical Carcinogenesis. Elsevier, Amsterdam, pp. 193-200.
8. Bourguin, A., Tung, R., Galili, N. and Sklar, J. (1990) Rapid, nonradioactive detection of clonal T-cell receptor gene rearrangements in lymphoid neoplasms. Proc. Natl. Acad. Sci. USA, 87, 8536-8540.
9. Burkhart-Schultz, K., Thomas, C.B., Thompson, C.L., Strout, C.L., Brinson, E. and Jones, I.M. (1993) Characterization of m vivo somatic mutations at the hypoxanthine phosphoribosyltransferase gene of a human control population. Environ. Health Perspect., 101, 68-74.
10. Cariello, N.F. (1994) Software for the analysis of mutations at the human hprt gene. Mutat. Res., 312, 173-185. (Release 5 refers to the 5th version of the database described in this reference).
11. Cochrane, J.E. and Skopek, T.R. (1994) Mutagenicity of butadiene and its epoxide metabolites: II. Mutational spectra of butadiene, 1,2-epoxybutene and diepoxybutane at the hprt locus in splenic T cells from exposed B6C3F1 mice. Carcinogenesis, 15, 719-723.
12. Curry, J., Rowley, G.T., Saddi, V., Beare, D., Cole, J. and Glickman, B.W. (1995) Determination of hprt mutant and mutation frequencies and the molecular characterization of human derived in vivo T-lymphocyte mutants. Environ. Mol. Mutagen., 25, 169-179.
13. de Boer, J.G., Curry, J.D. and Glickman, B.W. (1993) A fast and simple method to determine the clonal relationship among human T-cell lymphocytes. Mutat. Res., 288, 173-180.
14. Dietz, H.C., Valle, D., Francomano, C.A., Kendzior, R.J., Pyeritz, R.E. and Cutting, G.R. (1993) The skipping of constitutive exons in vivo induced by nonsense mutations. Science, 259, 680-683.
15. 6-methylguanine paired with cytosine or thymine in defined oligonucleotide sequences. Biochemistry, 30, 11595-11599.
16. Edwards, A., Voss, H., Rice, P., Civitello, A., Stegemann, J., Schwager, C., Zimmermann, J., Erfle, H., Caskey, C.T. and Ansorge, W. (1990) Automated DNA sequencing of the human hprt locus. Genomics, 6, 593-608.
17. Fuscoe, J.C., Zimmerman, L.J., Harrington-Brock, K. and Moore, M.M. (1992) Large deletions are tolerated at the hprt locus of in vivo derived human T-lymphocytes. Mutat. Res., 283, 255-262.
18. Gibbs, R.A., Nguyen, P.N., Edwards, A., Civitello, A.B. and Caskey, C.T. (1990) Multiplex DNA deletion detection and exon sequencing of the hypoxanthine phosphoribosyltransferase gene in Lesch-Nyhan families Genomics, 7, 235-244.
19. Henning, E.E., Conney, A.H. and Wei, S.-J.C. (1995) Characterization of hprt splicing mutations induced by the ultimate carcinogenic metabolite of benzo[a]pyrene in Chinese hamster V-79 cells. Cancer Res., 55, 1550-1558.
20. 32P-postlabelling detection of DNA adducts in mononuclear cells of workers occupationally exposed to styrene. Carcinogenesis, 15, 1309-1315.
21. Hou, S.-M., Steen, A.-M., Fält, S. and Andersson, B. (1993) Molecular spectrum of background mutation at the hprt locus in human T-lymphocytes. Mutagenesis, 8, 43-49.
22. IARC (1994) Some industrial chemicals. Monographs on the Evaluation of Carcinogenic Risks to Humans. IARC Scientific Publication No. 60. International Agency for Research on Cancer, Lyon.
23. 6-alkylguanine in hprt mutagenesis in T-lymphocytes of rats exposed in vivo to ethylmethanesulfonate, N-(2-hydroxyethyl)-N-nitrosourea, or N-ethyl-N-nitrosourea. Cancer Res., 55, 1875-1882.
24. Latham, G.J., Harris, C.M., Harris, T.M. and Lloyd, R.S. (1995) The efficiency of translesion synthesis past single styrene oxide DNA adducts in vitro is polymerase-specific. Chem. Res. Toxicol., 8, 422-430.
25. 6 is dependent on both the chirality of the lesion and the local sequence context. J. Biol. Chem., 268, 23427-23434.
26. Lichtenauer-Kaligis, E.G.R., Thijssen, J.C.P., den Dulk, H., van de Putte, P., Giphart-Gassler, M. and Tasserong-de Jong, J.G. (1995) Spontaneous mutation spectrum in the hprt gene in human lymphoblastoid TK6 cells. Mutagenesis, 10, 137-143.
27. Manjanatha, M.G., Lindsey, L.A., Mittelstaedt, R.A. and Heflich, R.H. (1994) Low hprt mRNA levels and multiple hprt mRNA species in 6-thioguanine-resistant Chinese hamster cell mutants possessing nonsense mutations. Mutat. Res., 308, 65-75.
28. Menichini, P., Inga, A., Fronza, G., Iannone, R., Degan, P., Campomenosi, P. and Abbondandolo, A. (1994) Defective splicing induced by 4NQO in the hamster hprt gene. Mutat. Res., 323, 159-165.
29. Nakajima, T., Elovaara, E., Gonzales, F.J., Gelboin, H.V., Vainio, H. and Aoyama, T. (1993) Characterization of human cytochrome P450 isozymes responsible for styrene metabolism. In Sorsa, M., Peltonen, K., Vainio, H. and Hemminki, K. (eds), Butadiene and Styrene: Assessment of Health Hazards. International Agency for Research on Cancer, Lyon, pp. 101-108.
30. Österholm, A.-M., Fält, S., Lambert, B. and Hou, S.-M. (1995) Classification of mutations at the human hprt-locus in T-lymphocytes of bus maintenance workers by multiplex-PCR and reverse transcriptase-PCR analysis. Carcinogenesis, 16, 1909-1912.
31. Recio, L., Cochrane, J., Simpson, D., Skopek, T.R., O'Neill, J.P., Nicklas, J.A. and Albertini, R.J. (1990) DNA sequence analysis of in vitro hprt mutation in human T lymphocytes. Mutagenesis, 5, 505-510.
32. Recio, L. and Meyer, K.G. (1995) Increased frequency of mutations at A:T base pairs in the bone marrow of B6C3F1 lac1 transgenic mice exposed to 1, 3-buladiene. Environ. Mol. Mutagen., 26, 1-8.
33. Rossi, A.M., Thijssen, J.C.P., Tates, A.D., Vrieling, H., Natarajan, A.T., Lohman, P.H.M. and van Zeeland, A.A. (1990) Mutations affecting RNA splicing in man are detected more frequently in somatic than in germ cells. Mutat. Res., 244, 353-357.
34. Savela, K., Hesso, A. and Hemminki, K. (1986) Characterization of reaction products between styrene oxide and deoxynucleosides and DNA. Chem. Biol. Interact., 60, 235-246.
35. Schaaper, R.M., Kunkel, T.A. and Loeb, L.A. (1983) Infidelity of DNA synthesis associated with bypass of apurinic sites. Proc. Natl. Acad. Sci. USA, 80, 487-491.
36. Shimahara, H., Kato, T., Hirai, Y. and Akiyama, M. (1995) Spectrum of in vivo hprt mutations in T lymphocytes from atomic bomb survivors. I. Sequence alterations in cDNA. Carcinogenesis, 16, 583-591.
37. Smooker, P.M., Christodoulou, J., McInnes, R.R. and Cotton, R.G.H. (1995) A mutation causing DHPR deficiency results in a frameshift and a secondary splicing defect. J. Med. Genet., 32, 220-223.
38. Steingrimsdottir, H., Rowley, G., Dorado, G., Cole, J. and Lehmann, A.R. (1992) Mutations which alter splicing in the human hypoxanthine-guanine phosphoribosyltransferase gene. Nucleic Acids Res., 20, 1201-1208.
39. Steingrimsdottir, H., Rowley, G., Waugh, A., Beare, D., Ceccherini, I., Cole, J. and Lehmann, A.R. (1993) Molecular analysis of mutations in the hprt gene in circulating lymphocytes from normal and DNA-repair-deficient donors. Mutat. Res., 294, 29-41.
40. Valentine, C.R. and Heflich, R.H. (1995a) Genomic DNA sequencing of mRNA splicing mutants in the hprt gene of Chinese hamster ovary cells. Environ. Mol. Mutagen., 25, 85-96.
41. Valentine, C.R. and Heflich, R.H. (1995b) mRNA species with exon deletions prevalent in nonsense mutants of the hprt gene of CHO cells are present in low abundance in wild-type cell lines. Environ. Mol. Mutagen., 25 (S25), 55.
42. 6-guanine DNA adducts, DNA strand breaks and mutant frequencies in the hypoxanthine guanine phosphoribosyltransferase gene in T-lymphocytes. Carcinogenesis, 16, 1473-1481.
43. Vodička, P. and Hemminki, K. (1988) Identification of alkylation products of styrene oxide in single- and double-stranded DNA. Carcinogenesis, 9, 1657-1660.
44. 32P-postlabeling of DNA adducts of styrene-exposed lamination workers. Carcinogenesis, 14, 2059-2061.
45. 32P-postlabelling. Carcinogenesis, 15, 1949-1953.
46. Vrieling, H., Thijssen, J.C.P., Rossi, A.M., van Dam, F.J., Natarajan, A.T., Tates, A.D. and van Zeeland, A.A. (1992) Enhanced hprt mutant frequency but no significant difference in mutation spectrum between a smoking and a non-smoking human population. Carcinogenesis, 13, 1625-1631.
47. Walker, V.E. and Skopek, T.R. (1993) A mouse model for the study of in vivo mutational spectra: sequence specificity of ethylene oxide at the hprt locus. Mutat. Res., 288, 151-162.
48. Yang, J.L., Maher, V.M. and McCormick, J.J. (1989) Amplification and direct nucleotide sequencing of cDNA from the lysate of low numbers of diploid human cells. Gene, 83, 347-354.
49. Zhang, L.-H., Vrieling, H., van Zeeland, A.A. and Jenssen, D. (1992) Spectrum of spontaneously occurring mutations in the hprt gene of V79 Chinese hamster cells. J. Mol. Biol., 223, 627-635.